Precision Epigenomics

Medical Devices & EquipmentSeries ATucson, USprecision-epigenomics.com

Latest round

Series A

Last raised

Mar 2024

Total raised

$1.1M

Investors

2

About Precision Epigenomics

Based in Arizona, US, and founded in 2021 by co-founder and CEO Mark A., formerly known as DesertDX, LLC, operates as a provider of the EPISEEK liquid biopsy test to adults, particularly those aged 45 and older, for early cancer detection. In March 2024, Precision Epigenomics Inc. The company provides early cancer detection services, including the EPISEEK test, which identifies specific cancer-related DNA methylation patterns from a simple blood draw. The test can detect up to 20 types of cancer, including in early stages. Additionally, the firm also provides comprehensive test result interpretation and support services for healthcare providers.

Who invested in Precision Epigenomics

2 investors across 1 round

See all investors in Precision Epigenomics

Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.

Funding rounds

  1. Series A

    Mar 18, 2024

    Amount

    $1.1M

    Investors

    Locked

Questions about Precision Epigenomics

Who invested in Precision Epigenomics?

Precision Epigenomics has 2 investors on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.

How much funding has Precision Epigenomics raised?

Precision Epigenomics has raised 1 venture round. Sign up free to see how much each round raised and the total.

When did Precision Epigenomics last raise money?

Precision Epigenomics's most recent round on record is a Series A, in Mar 2024.

What does Precision Epigenomics do?

Based in Arizona, US, and founded in 2021 by co-founder and CEO Mark A.

Where is Precision Epigenomics headquartered?

Precision Epigenomics is headquartered in Tucson, US.

Which VCs invest in companies like Precision Epigenomics?

Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back medical devices & equipment companies at Precision Epigenomics's stage. Their profiles are linked below.

Raising like Precision Epigenomics? Find the right VCs.

Capital Atlas matches your startup to active investors by stage, sector and region.

Free to start. Upgrade when you're ready to reach out.